Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Knobbe Martens Secures Patent for the Cure of the Common Cold

September 10, 2015  | Mark Benedict and Mark Metzke, Ph.D.

Knobbe Martens attorneys, Mark Benedict and Mark Metzke, were featured in “Patent a Cure for the Common Cold? This Lawyer Did” appearing on Corporate Counsel‘s website. The article discusses the work we are doing with our client, Dr. Bruce May, on the cure for the common cold.

Read the full article on Law.com >> (Subscription required)

View the November 2015 digital edition of Corporate Counsel >>

Related Links

Practice Areas

Industries

News & Insights

News
May 2026
Three Knobbe Martens Partners Named Among Top IP Lawyers in California by Daily Journal
Sheila Swaroop, Brian Horne and Joseph Re recognized for strength in intellectual property litigation IRVINE, Calif., May 20, 2026 – Reflecting the firm’s strengths in high-stakes litigation, Knobbe Martens is...
Blog - Biotechnology
May 2026
Federal Circuit Confirms Patent Eligibility of Gene Therapy Patent in Regenexbio Inc. v. Sarepta Therapeutics
Key Takeaway: Genetically engineered cultured host cells containing recombinant nucleic acids useful for gene therapy are patent-eligible for being markedly different from anything occurring in nature. In REGENXBIO Inc. v....
Publications
May 2026
USPTO Director Signals Continued Pro-Patent Discretionary Denial Policy at the Patent Trial and Appeal Board
Key Takeaway: In a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc., USPTO Director Squires denied IPR institution and reinforced the policy framework for discretionary denial at the...